Specifically, Paramasivan et al. used discovery proteomics to profile for the trioxidation (sulfonylation) of human serum albumin in healthy and type 2 diabetes patients and found that more trioxidized forms of the albumin were present in the diabetic patients [157]. The gene discussed is ALB; the disease is type 2 diabetes mellitus.